A Study of Evacetrapib in Healthy Female Participants

NCT01746732 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Ortho-Cyclen
DRUG: Evacetrapib

Sponsor

Eli Lilly and Company